|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 445.20 GBX | -0.27% |
|
+1.57% | -0.51% |
| 07-15 | Rollins Faces Mixed Q2 Setup as Soft Organic Growth Offsets Pest Control Strength, UBS Says | MT |
| 07-13 | WINNERS & LOSERS: Vodafone extends rally; ME Group sales back on track | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (USD) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.65 | 3.65 | 3.98 | 3.87 | 3.97 | |||||
Return on Total Capital | 6.17 | 4.63 | 4.98 | 4.87 | 4.96 | |||||
Return On Equity % | 21.98 | 8.65 | 9.31 | 7.38 | 5.38 | |||||
Return on Common Equity | 21.99 | 8.65 | 9.31 | 7.38 | 5.37 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 80.07 | 80.59 | 82.75 | 83.87 | 13.77 | |||||
SG&A Margin | 54.37 | 53.9 | 53.4 | 54.38 | - | |||||
EBITDA Margin % | 19.14 | 19.01 | 19.57 | 18.25 | 17.85 | |||||
EBITA Margin % | 14.8 | 15.24 | 16.71 | 15.32 | 15.43 | |||||
EBIT Margin % | 12.48 | 12.79 | 13.66 | 12.36 | 12.7 | |||||
Income From Continuing Operations Margin % | 8.9 | 6.25 | 7.09 | 5.65 | 4.2 | |||||
Net Income Margin % | 8.9 | 6.25 | 7.09 | 5.65 | 6.8 | |||||
Net Avail. For Common Margin % | 8.9 | 6.25 | 7.09 | 5.65 | 4.2 | |||||
Normalized Net Income Margin | 7.28 | 7.27 | 6.87 | 5.99 | 6.15 | |||||
Levered Free Cash Flow Margin | 7 | 14.31 | 9.48 | 9.95 | 11.99 | |||||
Unlevered Free Cash Flow Margin | 7.7 | 15.56 | 11.51 | 12.03 | 14.13 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.6 | 0.46 | 0.47 | 0.5 | 0.5 | |||||
Fixed Assets Turnover | 4.75 | 4.72 | 5.67 | 5.68 | 6.21 | |||||
Receivables Turnover (Average Receivables) | 6.24 | 5.47 | 6.29 | 6.08 | 6.04 | |||||
Inventory Turnover (Average Inventory) | 4.41 | 4.29 | 4.56 | 4.02 | 20.02 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.97 | 1.14 | 1.05 | 0.81 | 1.16 | |||||
Quick Ratio | 0.84 | 1.07 | 0.97 | 0.72 | 1.07 | |||||
Operating Cash Flow to Current Liabilities | 0.41 | 0.21 | 0.29 | 0.26 | 0.29 | |||||
Days Sales Outstanding (Average Receivables) | 58.51 | 66.78 | 58.06 | 60.23 | 60.45 | |||||
Days Outstanding Inventory (Average Inventory) | 82.69 | 85.05 | 80.13 | 90.98 | 18.23 | |||||
Average Days Payable Outstanding | 106.82 | 119.96 | 138.34 | 136.79 | 23.69 | |||||
Cash Conversion Cycle (Average Days) | 34.38 | 31.87 | -0.15 | 14.41 | 54.98 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 152.89 | 133.92 | 116.93 | 97.94 | 111.99 | |||||
Total Debt / Total Capital | 60.46 | 57.25 | 53.9 | 49.48 | 52.83 | |||||
LT Debt/Equity | 110.4 | 97.56 | 85.3 | 67.22 | 83.11 | |||||
Long-Term Debt / Total Capital | 43.65 | 41.71 | 39.32 | 33.96 | 39.2 | |||||
Total Liabilities / Total Assets | 70.76 | 65.63 | 63.26 | 59.94 | 61.94 | |||||
EBIT / Interest Expense | 11.08 | 6.42 | 4.19 | 3.71 | 3.7 | |||||
EBITDA / Interest Expense | 19.35 | 10.74 | 6.7 | 6.16 | 5.88 | |||||
(EBITDA - Capex) / Interest Expense | 15.51 | 8.68 | 5.74 | 5.22 | 5 | |||||
Total Debt / EBITDA | 3 | 6.9 | 4.08 | 3.71 | 4.42 | |||||
Net Debt / EBITDA | 1.96 | 4.17 | 2.73 | 2.88 | 2.71 | |||||
Total Debt / (EBITDA - Capex) | 3.74 | 8.55 | 4.76 | 4.39 | 5.19 | |||||
Net Debt / (EBITDA - Capex) | 2.44 | 5.17 | 3.19 | 3.4 | 3.18 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 5.47 | 25.6 | 44.72 | 1.13 | 4.4 | |||||
Gross Profit, 1 Yr. Growth % | 6.77 | 26.77 | 48.61 | 1.88 | 14.03 | |||||
EBITDA, 1 Yr. Growth % | 10.46 | 24.51 | 41.59 | -5.7 | 5.2 | |||||
EBITA, 1 Yr. Growth % | 15.01 | 28.93 | 48.92 | -7.24 | 10.12 | |||||
EBIT, 1 Yr. Growth % | 16.96 | 28.38 | 43.36 | -8.45 | 14.94 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 41.28 | -11.79 | 64.22 | -19.42 | -16.18 | |||||
Net Income, 1 Yr. Growth % | 41.28 | -11.79 | 64.22 | -19.42 | 19.9 | |||||
Normalized Net Income, 1 Yr. Growth % | 35.02 | 25.22 | 26.01 | -11.84 | 18.88 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 41.28 | -18.37 | 30.93 | -19.44 | -16.44 | |||||
Accounts Receivable, 1 Yr. Growth % | -12.15 | 57.87 | 6.02 | 3.3 | 1.23 | |||||
Inventory, 1 Yr. Growth % | 3.35 | 47.06 | 3.5 | 10.63 | 7.32 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.87 | 51.6 | 0.74 | 1.26 | -15.27 | |||||
Total Assets, 1 Yr. Growth % | -22.57 | 175.72 | -6.82 | -5.15 | 9.26 | |||||
Tangible Book Value, 1 Yr. Growth % | 13.66 | 261.81 | -7.97 | -2.49 | -5.25 | |||||
Common Equity, 1 Yr. Growth % | 11.92 | 224.03 | -0.24 | 3.42 | 3.8 | |||||
Cash From Operations, 1 Yr. Growth % | 7.6 | 6.57 | 22.83 | -8.01 | 11.98 | |||||
Capital Expenditures, 1 Yr. Growth % | -1.62 | 19.53 | 9.15 | 2.4 | -5.02 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -58.39 | 149 | -9.16 | 6.18 | 31.27 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -56.41 | 146.17 | 1.94 | 5.7 | 26.13 | |||||
Dividend Per Share, 1 Yr. Growth % | 18.11 | 18.15 | 14.97 | 4.72 | 2.74 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 4.37 | 15.11 | 34.82 | 20.98 | 4.01 | |||||
Gross Profit, 2 Yr. CAGR % | 5.03 | 16.27 | 37.26 | 23.07 | 2.57 | |||||
EBITDA, 2 Yr. CAGR % | 6.28 | 16.86 | 34.68 | 15.16 | -1.23 | |||||
EBITA, 2 Yr. CAGR % | 8.2 | 21.25 | 40.95 | 17.05 | -0.33 | |||||
EBIT, 2 Yr. CAGR % | 12.09 | 25.21 | 39.35 | 17.11 | 1.28 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -3.7 | 11.68 | 20.36 | 15.03 | -18.54 | |||||
Net Income, 2 Yr. CAGR % | -3.7 | 11.68 | 20.36 | 15.03 | -0.42 | |||||
Normalized Net Income, 2 Yr. CAGR % | 14.64 | 33.61 | 29.39 | 7.96 | 0 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -3.81 | 7.39 | 3.38 | 2.7 | -18.66 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.97 | 28.41 | 29.22 | 4.65 | 1.33 | |||||
Inventory, 2 Yr. CAGR % | 12.88 | 23.42 | 23.37 | 7 | 8.01 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.03 | 23.7 | 23.25 | 1 | -8.22 | |||||
Total Assets, 2 Yr. CAGR % | 0.81 | 46.13 | 60.42 | -5.99 | 0.92 | |||||
Tangible Book Value, 2 Yr. CAGR % | 16.06 | 102.64 | 82.02 | -5.27 | -4.7 | |||||
Common Equity, 2 Yr. CAGR % | 12.35 | 90.48 | 79.79 | 1.57 | 2.71 | |||||
Cash From Operations, 2 Yr. CAGR % | 10.3 | 4.64 | 14.41 | 6.3 | 3.01 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.49 | 8.49 | 14.22 | 5.72 | 0.24 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -18.27 | 4.59 | 51.99 | -3.93 | 17.41 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -18.91 | 6.34 | 59.98 | 1.71 | 15.29 | |||||
Dividend Per Share, 2 Yr. CAGR % | 105.71 | 18.13 | 16.55 | 9.73 | 6.86 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.14 | 11.02 | 24.24 | 22.5 | 11.39 | |||||
Gross Profit, 3 Yr. CAGR % | 6.53 | 11.73 | 26.18 | 24.53 | -38.31 | |||||
EBITDA, 3 Yr. CAGR % | 6 | 12.11 | 26.72 | 19.59 | 6.99 | |||||
EBITA, 3 Yr. CAGR % | 8.32 | 14.83 | 32.62 | 22.6 | 9.21 | |||||
EBIT, 3 Yr. CAGR % | 9.23 | 17.39 | 34.3 | 21.14 | 9.97 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 38.86 | -6.5 | 27 | 5.29 | -2.43 | |||||
Net Income, 3 Yr. CAGR % | 38.86 | -6.5 | 27 | 5.29 | 14.6 | |||||
Normalized Net Income, 3 Yr. CAGR % | 10.18 | 18.14 | 34.67 | 13.86 | 4.17 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 38.13 | -8.93 | 14.73 | -4.87 | -9.61 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.42 | 24.15 | 20.37 | 19.93 | 1 | |||||
Inventory, 3 Yr. CAGR % | 9.56 | 23.37 | 16.39 | 18.97 | 4.59 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.71 | 15.69 | 15.31 | 15.44 | -7.03 | |||||
Total Assets, 3 Yr. CAGR % | 11.95 | 40.99 | 25.84 | 34.64 | -3.52 | |||||
Tangible Book Value, 3 Yr. CAGR % | 10.15 | 69.46 | 55.5 | 47.83 | -7.53 | |||||
Common Equity, 3 Yr. CAGR % | 14.96 | 59.95 | 53.54 | 49.53 | -0.13 | |||||
Cash From Operations, 3 Yr. CAGR % | 15.7 | 9.03 | 10.38 | 6.39 | 6.37 | |||||
Capital Expenditures, 3 Yr. CAGR % | -4.6 | 2.98 | 8.71 | 10.14 | 0.34 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 0.3 | 19.74 | 1.58 | 34.86 | 1.63 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -1.65 | 18.62 | 6.59 | 39.34 | 4.68 | |||||
Dividend Per Share, 3 Yr. CAGR % | 12.64 | 71 | 17.07 | 12.47 | 6.83 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.4 | 9.01 | 16.8 | 14.9 | 12.86 | |||||
Gross Profit, 5 Yr. CAGR % | 5.73 | 9.09 | 17.83 | 16.26 | -20.42 | |||||
EBITDA, 5 Yr. CAGR % | 2.97 | 7.01 | 17.23 | 14.64 | 12.12 | |||||
EBITA, 5 Yr. CAGR % | 7.79 | 8.91 | 21.13 | 17.38 | 15.52 | |||||
EBIT, 5 Yr. CAGR % | 7.47 | 8.53 | 20.99 | 18.01 | 16.55 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.42 | -19.42 | 31.12 | 1.58 | 2.99 | |||||
Net Income, 5 Yr. CAGR % | 9.42 | -19.42 | 31.12 | 1.58 | 13.43 | |||||
Normalized Net Income, 5 Yr. CAGR % | 8.88 | 8.99 | 18.09 | 14.74 | 15.86 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.13 | -20.78 | 23.01 | -4.45 | -3.16 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7 | 17.32 | 16.36 | 15.89 | 11.13 | |||||
Inventory, 5 Yr. CAGR % | 11.15 | 18.86 | 14.94 | 16.55 | 11.75 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 8.49 | 19.45 | 16.83 | 9.46 | 4.11 | |||||
Total Assets, 5 Yr. CAGR % | 11.2 | 30.85 | 29.28 | 19.93 | 13.95 | |||||
Tangible Book Value, 5 Yr. CAGR % | 7.17 | 63.59 | 34.62 | 34.15 | 26.43 | |||||
Common Equity, 5 Yr. CAGR % | 28.52 | 34.43 | 37.49 | 33.38 | 29.3 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.29 | 9.58 | 15.18 | 7.93 | 5.68 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.25 | -2.57 | 2.56 | 4.07 | 3.52 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 65.42 | 10.77 | 19.96 | 11.8 | 4.83 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 37.09 | 10.65 | 20.92 | 13.57 | 7.26 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.65 | 14.24 | 14.19 | 43.19 | 11.22 |
- Stock Market
- Stocks
- RTO Stock
- Financials Rentokil Initial plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















